Status | Study |
RECRUITING |
Study Name: A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis Condition: Colitis, Ulcerative Date: 2023-09-15 Interventions: JNJ-77242113 tablet will be administered orally. |
Recruiting |
Study Name: GSK2982772 Study in Ulcerative Colitis Patients Condition: Colitis, Ulcerative Date: 2016-09-13 Interventions: Drug: GSK2982772 GSK2982772 is |
Active, not recruiting |
Study Name: An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis Condition: Colitis, Ulcerative Date: 2015-11-06 Interventions: Drug: GED-0301 Other Name: Mongersen |
Active, not recruiting |
Study Name: The Utility of Second Generation Colon Capsule Endoscopy in Ulcerative Colitis Condition: Colitis, Ulcerative Date: 2015-06-09 Interventions: Device: C2 C2 and colonoscopy |
Active, not recruiting |
Study Name: Golimumab in Steroid-dependent Ulcerative Colitis: Induction and Maintenance of Clinical and Endoscopic Remission Condition: Colitis, Ulcerative Date: 2015-03-26 Interventions: Drug: Golimumab Subcutaneous golimumab. Induction regimen: |
Terminated |
Study Name: Efficacy/Safety Pilot Study to Investigate Iberogast N's Efficacy in Mild to Moderate Colitis Ulcerosa Patients Condition: Colitis, Ulcerative Date: 2014-09-19 Interventions: Drug: STW5-II (Iberogast N, BAY98-7410) |
Active, not recruiting |
Study Name: Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea Condition: Colitis, Ulcerative Date: 2014-08-28 Interventions: Other: No Intervention Participants with newly diagnosed moderate to severe ulcerative colitis in a tert |
Completed |
Study Name: Randomized-controlled Trial of Yoga for Ulcerative Colitis Condition: Colitis, Ulcerative Date: 2014-01-21 Interventions: Behavioral: Yoga 12-week Hatha |
Terminated |
Study Name: Safety and Tolerability Study of GSK2586184 in Patients With Moderate to Severely Active Ulcerative Colitis. Condition: Colitis, Ulcerative Date: 2013-11-27 Interventions: Drug: GSK2586184 400mg White film coated round biconvex GSK2586184 200 mg tablets, administered 2 X twic |
Completed |
Study Name: A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis Condition: Colitis, Ulcerative Date: 2013-11-14 Interventions: Biological: Golimumab SC injections Other Name: SIMP |